Size: 10mg
Contents: Retatrutide
Form: Lyophilized powder
Purity: >99%
Retatrutide 10mg is a next-generation, high-purity research peptide engineered as a triple receptor agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. Developed exclusively for in-vitro and preclinical research, it is designed to support advanced investigations into metabolic signaling, energy balance, and endocrine system interactions.
With its increased 10mg quantity, this format is ideal for extended studies and scalable experimental protocols. Retatrutide stands at the forefront of incretin-based research, enabling scientists to explore synergistic effects across multiple metabolic pathways within a single compound.
Retatrutide 10mg is widely recognized for its ability to simultaneously activate three critical receptor systems involved in metabolic regulation. Unlike single or dual agonist peptides, this triple-action compound provides a more comprehensive approach to studying glucose metabolism, lipid utilization, and energy expenditure.
Researchers focused on obesity biology, metabolic disorders, and endocrine pharmacology rely on Retatrutide for its advanced mechanism and broad research potential. Its multi-pathway activity allows for deeper insights into how interconnected metabolic systems function and adapt.
Peptide Type: Triple incretin receptor agonist
Compound: Retatrutide
Target Receptors: GLP-1, GIP, and glucagon receptors
Primary Function: Metabolic regulation and multi-pathway signaling research
Retatrutide 10mg functions by binding to and activating GLP-1, GIP, and glucagon receptors simultaneously. This triple receptor engagement is believed to influence multiple metabolic processes, including insulin secretion, glucose regulation, and energy expenditure.
Activation of GLP-1 and GIP receptors may support insulin signaling and glucose homeostasis, while glucagon receptor activity is associated with increased metabolic rate and energy utilization. These combined actions involve complex intracellular signaling pathways, making Retatrutide a powerful tool for studying integrated metabolic responses.
Retatrutide 10mg is widely utilized in laboratory studies focused on:
Its triple-agonist mechanism makes it essential for advanced metabolic and endocrine research.
In controlled research environments, Retatrutide has demonstrated strong activity across multiple metabolic pathways. Its ability to engage three receptor systems simultaneously may provide enhanced modulation of glucose balance, energy expenditure, and lipid metabolism compared to single-pathway compounds.
Ongoing studies continue to explore its broader role in metabolic efficiency, weight regulation, and endocrine signaling, positioning Retatrutide as a leading compound in next-generation peptide research.
Product Name: Retatrutide
Quantity: 10mg per vial
Form: Lyophilized powder
Purity: ≥99%
Store Retatrutide 10mg in a cool, dry place away from direct light. Refrigeration is recommended to maintain stability, especially after reconstitution in research settings.
Retatrutide 10mg is intended strictly for research and laboratory use only. It is not approved for human consumption, veterinary use, or therapeutic applications. All handling must be performed by qualified professionals in compliance with applicable laws and regulations.
